ZNF703 promotes triple-negative breast cancer cells through cell-cycle signaling and associated with poor prognosis.

导出 OA

翻译打印收藏纠错

作者： Xi,Zhang ^[1] ; Xin,Mu ^[2] ; Ou,Huang ^[3] ; Zhitang,Wang ^[4] ; Jialin,Chen ^[5] ; Debo,Chen ^[5] ; Gen,Wang ^[6]

作者单位： Department of Breast Oncology, The First Hospital of Quanzhou Affiliated to Fujian Medical University, Anji Rd, 362000, Quanzhou, China. Hee_rainday@foxmail.com. ^[1] Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 200025, Shanghai, China. Hee_rainday@foxmail.com. ^[2] Department of Urology, The Second Affiliated Hospital of Fujian Medical University, 362000, Quanzhou, China. ^[3] Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 200025, Shanghai, China. ^[4] Department of Breast Oncology, The First Hospital of Quanzhou Affiliated to Fujian Medical University, Anji Rd, 362000, Quanzhou, China. ^[5] Department of Breast Oncology, The First Hospital of Quanzhou Affiliated to Fujian Medical University, Anji Rd, 362000, Quanzhou, China. deboqz@163.com. ^[6] Department of Pharmacology, School of Pharmacy, Fujian Provincial Key Laboratory of Natural Medicine Pharmacology, Fujian Medical University, University Town, 1 Xue Yuan Road, 350122, Fuzhou, China. wanggenjiushiwo@outlook.com. ^[7]

关键词 Cell cycle Cell proliferation Prognosis Triple-negative breast cancer ZNF703